Lv3
216 积分 2023-08-04 加入
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy
14天前
已完结
Discovery ofaNovel Series of iso -Indolinone-Based Glutarimidesas Highly Efficacious and SelectiveIKZF2 Molecular Glue Degraders
21天前
已完结
Mechanism of Action and Novel IMiD-Based Compounds and Combinations in Multiple Myeloma
21天前
已完结
Discovery of a Novel Series of iso-Indolinone-Based Glutarimides as Highly Efficacious and Selective IKZF2 Molecular Glue Degraders
21天前
已完结
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy
25天前
已完结
PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies
30天前
已完结
Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer
30天前
已完结
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy
1个月前
已完结
Comparison of crystal structures of human androgen receptor ligand‐binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity
2个月前
已完结
Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer
2个月前
已完结
皖公网安备34019202002308
